SlideShare a Scribd company logo
Maternal
Near Miss
Prof. Aboubakr
Elnashar
Benha University Hospital,
Egypt
elnashar53@hotmail.com
ABOUBAKR ELNASHAR
CONTENTS
I. MATERNAL MORTALITY
1. Definitions
2. Why is not sufficient?
II. MATERNAL NEAR MISS
1. Concept
2. Definition
3. Criteria
4. Indicators
5. Review
6. Advantages
7. Reduction of MM
8. Studies
 CONCLUSION
ABOUBAKR ELNASHAR
I. MATERNAL MORTALITY
1. DEFINITIONS
Maternal Death: MD
The death of a woman while
pregnant, or
within 42 days of termination of pregnancy,
irrespective of the duration and the site of the
pregnancy,
from any cause
related to or aggravated by the pregnancy or its
management (from direct or indirect obstetric
death)
but not from accidental or incidental causes.
ABOUBAKR ELNASHAR
Maternal Mortality Rate Vs Ratio
Many sources use the maternal mortality ratio and
the maternal mortality rate interchangeably
to mean the number of maternal deaths per 100,000
live births.
WHO, however, distinguishes the two:
ABOUBAKR ELNASHAR
Maternal mortality ratio:
The number of maternal deaths per 100,000 live
births
a measure of the risk of death once a woman has
become pregnant.
In Egypt: 2016
Number of maternal deaths: 1194
Live births: 2 600 173
MM Ratio: 45.9
ABOUBAKR ELNASHAR
Maternal mortality rate:
The number of maternal deaths (direct and indirect)
in a given period per 100,000 women of reproductive
age during the same time period.
ABOUBAKR ELNASHAR
2. WHY MM IS NOT SUFFICIENT?
 Maternal mortality (MM)
 Now
not considered sufficient for evaluation of obstetric
health in isolation.
1. Maternal mortality is
 “just the tip of iceberg” with a vast base to the
iceberg-maternal morbidity-which
 remains un-described,
 relatively unevaluated.
ABOUBAKR ELNASHAR
ABOUBAKR ELNASHAR
2. MMR has declined globally, more so in developed
countries.
3. Absolute number of maternal deaths is low
 it does not allow reliable quantitative analysis of
maternal health.
 In Egypt MMR has fallen from
1992: 174
2016: 46
ABOUBAKR ELNASHAR
3. Trends
Significant decline in the past 20 years.
From 2007 to 2013, there is no significant decrease in MMR
46
2016
ABOUBAKR ELNASHAR
II. MATERNAL NEAR MISS
1.CONCEPT
 Maternal near miss =
 Severe Acute Maternal Morbidity (SAMM)
 Women who experienced and survived a severe
life threatening condition during pregnancy, child
birth / postpartum
 cases share many characteristics with maternal
deaths
ABOUBAKR ELNASHAR
 Maternal near miss =
 emerged as
 an adjunct and proxy measure to identify gaps
in maternal health services
 complementary to maternal mortality
 inform about obstacles that have to be
overcome after the onset of an acute
complication.
 Corrective actions for identified problems
 can then be taken to reduce related mortality
and long-term morbidity.
ABOUBAKR ELNASHAR
2. DEFINITION
 “a woman who nearly died but survived a
complication that occurred during pregnancy,
childbirth or within 42 days of termination of
pregnancy”
(WHO,2004)
 In practical terms
 women are considered near miss cases when they
survive life-threatening conditions (i.e. organ
dysfunction).
 Woman who survives life threatening conditions
during pregnancy, abortion, and childbirth or within 42
days of pregnancy termination, irrespective of
receiving emergency medical/surgical interventions.
(Souza et al, 2007) ABOUBAKR ELNASHAR
3. CRITERIA FOR IDENTIFICATION
WHO recommended 3 approaches
1. Disease specific criteria
severe preeclampsia/eclampsia
severe hemorrhage
severe sepsis
uterine rupture.
2. Management/Intervention based
admission to ICU
obstetric hysterectomy
massive blood transfusion
intubation/ventilation.
ABOUBAKR ELNASHAR
3. Organ dysfunction based criteria –
 based on
 apparent clinical diseases,
 clinical markers
 management needs.
 The aim
 correction of that organ dysfunction
 arrest MNM progression to MD.
ABOUBAKR ELNASHAR
ABOUBAKR ELNASHAR
ABOUBAKR ELNASHAR
4. INDICATORS
 Useful for
 auditing quality of maternal health care
 assessing deficiencies and gaps between actual
use and optimal use of high priority interventions in
prevention and management of severe pregnancy
complications.
ABOUBAKR ELNASHAR
1. Severe maternal outcome ratio (SMOR)
 number of women with life-threatening
conditions (MNM + MD) per 1000 live births
(LB).
 This gives an estimate of
 the amount of care
 resources that would be needed in an area
or facility
 [SMOR= (MNM +MD)/LB].
ABOUBAKR ELNASHAR
2. MNM ratio (MNMR)
 number of maternal near-miss cases per 1000 live
births
 (MNMR = MNM/LB).
 It gives an estimation of
 the amount of care
 resources that would be needed in an area or
facility.
ABOUBAKR ELNASHAR
3. Maternal near-miss mortality ratio
 (MNM: 1 MD)
 refers to the ratio between maternal near-miss
cases and maternal deaths.
 Higher ratios indicate better care.
ABOUBAKR ELNASHAR
4. Mortality index
 number of maternal deaths divided by number of
women with life-threatening conditions
 expressed as a percentage [MI= MD/ (MNM +
MD)].
 The higher the index the more women with life-
threatening conditions die (low quality of care)
 The lower the index the fewer women with life-
threatening conditions die (better quality of care).
ABOUBAKR ELNASHAR
5. WHAT IS MNM REVIEW?
 Process of MNM Review (MNM-R) involves the
following steps:
1. Identification of MNM cases
2. Notification to MO/HOD
3. Data transmission (institute district state)
4. Review (institutional and district level)
5. Analysis and feedback for necessary action
ABOUBAKR ELNASHAR
6. ADVANTAGES
1. Near miss cases are more common than maternal
deaths:
 adequate information and analysis.
 statistically reliable quantitative analysis
 comprehensive profile of functioning of health care
system.
ABOUBAKR ELNASHAR
2. MNM shares MM.
 same pathway and pathological processes as
 Normal pregnancy
 Morbidity
 severe morbidity
 near miss
 Death
 The major reasons and causes:
valuable information regarding severe morbidity,
which, if untreated may lead to MM.
ABOUBAKR ELNASHAR
3. MNM-R seems to be less threatening to service
providers.
 In Cases of MDR, health professionals and other stakeholders involved
in service delivery are fearful that the blame would fall on their
shoulders.
 MDR process is considered as a potential threat to expose them to
public enquiry and outrage.
 Investigating the instances of MNM-R may be less threatening to
providers because the woman survived.
 In MNM R, fear of blame and punishment is less.
 are willing and eager to share their „success‟
stories.
 more valuable information can be obtained and
utilized for improvement of obstetric health and
reduction of MMR.
ABOUBAKR ELNASHAR
4. It enables us to learn from MNM survivors
as women themselves are available for interview about the
care they received.
They can share their experiences in ICU, psychological
devastation and trauma of being separated from newborn and
urge for breastfeeding, besides the psychological perspective
of other women who have faced severe maternal illness.
ABOUBAKR ELNASHAR
5. MNM-R provides valuable information about
 social and family problems
 lack of awareness of health care facilities.
 Level of delays can also be identified where they
occur.
ABOUBAKR ELNASHAR
7. SIGNIFICANCE IN REDUCING MATERNAL
MORTALITY
 MNM-R
 relatively simpler to analyze
 easier to resolve
 complementary to MDR in appraisal of maternal
health.
ABOUBAKR ELNASHAR
 When used in conjunction with MDR
1. aids in recognizing patterns and trends of
maternal morbidity and mortality
2. helps in identifying contributory factors of maternal
deaths so that actions can be taken at various
levels.
3. assists in evaluation of quality of health care at a
facility and to monitor it.
4. facilitates detection of lacunae in existing system.
ABOUBAKR ELNASHAR
5. helps in setting up a database to capture all locations and
facility details to identify where an MNM case comes from; this assists in
focusing interventions in a particular location.
6. beneficial in assessing and analyzing requirement
of health care facilities in terms of infrastructure, human resources
and interventional facilities, besides comparing the existing health care and
optimal health care of a facility.
ABOUBAKR ELNASHAR
7. identification of delays at various levels can be done,
which lead to maternal morbidity and mortality
8. identify modifiable socio-demographic factors
responsible for maternal morbidity and mortality.
9. It assists in international comparisons in imparting
optimal health care.
ABOUBAKR ELNASHAR
8. STUDIES
Arab countries
 Maternal mortality index
 Al Galaa hospital Egypt: 8.6 %
 Dar Al Tawleed hospital in Syria: 14.3 %
 countries with a moderate maternal mortality ratio
:5.6 %
(Bashour et al, 2015)
ABOUBAKR ELNASHAR
 MNM cases:
 haemorrhage-related complications were the most
frequent conditions
MNM dysfunction:
coagulation dysfunctions
cardiovascular dysfunctions.
(Bashour et al, 2015)
ABOUBAKR ELNASHAR
Kasr eleny Hospital
 The most common diagnosis encountered was
 Eclampsia: 58.7%
 Preeclampsia: 17.4%,
 APH and PPH: 8.7%
 Septic shock: 4.3%
 APP plus PPH in 2.2%
(Almonerary et al, 2012)
ABOUBAKR ELNASHAR
Number Percent
Organ dysfunction*
Cardiovascular dysfunction 76 59.4%
Respiratory dysfunction 8 6.3%
Renal dysfunction 4 3.1%
Coagulation/haematologic dysfunction 96 75.0%
Hepatic dysfunction 16 12.5%
Neurologic dysfunction 8 6.3%
Uterine hysterectomy 28 21.9%
Elgalaa Hospital
Organ dysfunction in Near-Miss Women (N=128)
(Elshishini et al, 2018)
ABOUBAKR ELNASHAR
 Near miss clinical audit:
 improve
 performance and quality of care
 maternal health outcome indicators.
 The Severe Maternal outcome
 can be used to monitor and assess the
performance and health care level.
ABOUBAKR ELNASHAR
Mansura university Hospital
Number and % of distribution of MNM and dead women
who experienced organ dysfunctions
(Mesbach et al, 2018)
ABOUBAKR ELNASHAR
 The main life threatening
sever pre-eclampsia
sever post partum hemorrhage.
 Cesarean Section was the main delivery mood for the
near misses (93%).
ABOUBAKR ELNASHAR
Elshatby university Hospital
 Severe pre-eclampsia: 40.2%
 post-partum hemorrhage: 23.8%
 Mortality index: 8.5%. .
(Sultan et al, 2017)
ABOUBAKR ELNASHAR
CONCLUSION
 Investigating MNM cases aids in
taking measures for further improvement of service
delivery and programs.
 MNM is a vital tool that can go a long way in reducing
maternal mortality.
 MNM-R
 an eminent adjunctive strategy to help identify
gaps in health service provision.
ABOUBAKR ELNASHAR
 MNM-R and MDR are complementary to each other.
 When used together, they help in recognizing the
contributory factors of maternal deaths so that
appropriate actions can be adopted at community and
health systems level.
ABOUBAKR ELNASHAR

More Related Content

What's hot

Recurrent pregnancy loss Presentation by Dr.Laxmi Shrikhande
Recurrent pregnancy loss Presentation by Dr.Laxmi ShrikhandeRecurrent pregnancy loss Presentation by Dr.Laxmi Shrikhande
Recurrent pregnancy loss Presentation by Dr.Laxmi Shrikhande
Dr.Laxmi Agrawal Shrikhande
 
Maternal near miss
Maternal near missMaternal near miss
Maternal near miss
Aboubakr Elnashar
 
Robson classification Dr. Iqra Malik.ppt
Robson classification Dr. Iqra Malik.pptRobson classification Dr. Iqra Malik.ppt
Robson classification Dr. Iqra Malik.ppt
Jawad Awan
 
Pop q (new)
Pop q (new)Pop q (new)
Pop q (new)
Osama Warda
 
Step wise pelvic devascularisation
Step wise pelvic devascularisationStep wise pelvic devascularisation
Step wise pelvic devascularisation
Niranjan Chavan
 
Laproscopy in gynecology oncology
Laproscopy in gynecology oncologyLaproscopy in gynecology oncology
Laproscopy in gynecology oncologyTariq Mohammed
 
THIRD AND FOURTH DEGREE TEARS
THIRD AND FOURTH DEGREE TEARSTHIRD AND FOURTH DEGREE TEARS
THIRD AND FOURTH DEGREE TEARS
Aboubakr Elnashar
 
Medicolegal aspects in obstetrics
Medicolegal aspects in obstetricsMedicolegal aspects in obstetrics
Medicolegal aspects in obstetrics
Aziza Negm
 
Premature ovarian failure
Premature ovarian failurePremature ovarian failure
Premature ovarian failureShambhu N
 
Recurrent pregnancy loss 1
Recurrent pregnancy loss 1Recurrent pregnancy loss 1
Recurrent pregnancy loss 1drmcbansal
 
Vulval ca and vulval lymph
Vulval ca and vulval lymphVulval ca and vulval lymph
Vulval ca and vulval lymph
hemnathsubedii
 
Role of hysteroscopy in Infertility, Dr Rajesh Gajbhiye
Role of hysteroscopy in Infertility, Dr Rajesh GajbhiyeRole of hysteroscopy in Infertility, Dr Rajesh Gajbhiye
Role of hysteroscopy in Infertility, Dr Rajesh Gajbhiye
Rajesh Gajbhiye
 
Medical Management of Fibroids
Medical Management of FibroidsMedical Management of Fibroids
Medical Management of Fibroids
Sujoy Dasgupta
 
Retained placenta
Retained placentaRetained placenta
Retained placenta
Niranjan Chavan
 
Tests for ovarian reserve
Tests for ovarian reserveTests for ovarian reserve
Tests for ovarian reserve
NARENDRA MALHOTRA
 
Presentation on Adherent placenta by Dr. Laxmi Shrikhande
Presentation on Adherent placenta by Dr. Laxmi Shrikhande Presentation on Adherent placenta by Dr. Laxmi Shrikhande
Presentation on Adherent placenta by Dr. Laxmi Shrikhande
Dr.Laxmi Agrawal Shrikhande
 
Cervical incompetence
Cervical incompetenceCervical incompetence
Cervical incompetence
Nikita Sharma
 
Cesarean Scar Ectopic Pregnancy Current Management Strategies
Cesarean Scar Ectopic Pregnancy Current Management StrategiesCesarean Scar Ectopic Pregnancy Current Management Strategies
Cesarean Scar Ectopic Pregnancy Current Management Strategies
Aboubakr Elnashar
 
Fibroid and infertility
Fibroid and infertilityFibroid and infertility
Fibroid and infertility
Aboubakr Elnashar
 

What's hot (20)

Recurrent pregnancy loss Presentation by Dr.Laxmi Shrikhande
Recurrent pregnancy loss Presentation by Dr.Laxmi ShrikhandeRecurrent pregnancy loss Presentation by Dr.Laxmi Shrikhande
Recurrent pregnancy loss Presentation by Dr.Laxmi Shrikhande
 
Maternal near miss
Maternal near missMaternal near miss
Maternal near miss
 
Robson classification Dr. Iqra Malik.ppt
Robson classification Dr. Iqra Malik.pptRobson classification Dr. Iqra Malik.ppt
Robson classification Dr. Iqra Malik.ppt
 
Pop q (new)
Pop q (new)Pop q (new)
Pop q (new)
 
Step wise pelvic devascularisation
Step wise pelvic devascularisationStep wise pelvic devascularisation
Step wise pelvic devascularisation
 
Laproscopy in gynecology oncology
Laproscopy in gynecology oncologyLaproscopy in gynecology oncology
Laproscopy in gynecology oncology
 
THIRD AND FOURTH DEGREE TEARS
THIRD AND FOURTH DEGREE TEARSTHIRD AND FOURTH DEGREE TEARS
THIRD AND FOURTH DEGREE TEARS
 
Medicolegal aspects in obstetrics
Medicolegal aspects in obstetricsMedicolegal aspects in obstetrics
Medicolegal aspects in obstetrics
 
Premature ovarian failure
Premature ovarian failurePremature ovarian failure
Premature ovarian failure
 
Recurrent pregnancy loss 1
Recurrent pregnancy loss 1Recurrent pregnancy loss 1
Recurrent pregnancy loss 1
 
Vulval ca and vulval lymph
Vulval ca and vulval lymphVulval ca and vulval lymph
Vulval ca and vulval lymph
 
Role of hysteroscopy in Infertility, Dr Rajesh Gajbhiye
Role of hysteroscopy in Infertility, Dr Rajesh GajbhiyeRole of hysteroscopy in Infertility, Dr Rajesh Gajbhiye
Role of hysteroscopy in Infertility, Dr Rajesh Gajbhiye
 
Medical Management of Fibroids
Medical Management of FibroidsMedical Management of Fibroids
Medical Management of Fibroids
 
Retained placenta
Retained placentaRetained placenta
Retained placenta
 
Tests for ovarian reserve
Tests for ovarian reserveTests for ovarian reserve
Tests for ovarian reserve
 
Presentation on Adherent placenta by Dr. Laxmi Shrikhande
Presentation on Adherent placenta by Dr. Laxmi Shrikhande Presentation on Adherent placenta by Dr. Laxmi Shrikhande
Presentation on Adherent placenta by Dr. Laxmi Shrikhande
 
Art f reduction
Art f reductionArt f reduction
Art f reduction
 
Cervical incompetence
Cervical incompetenceCervical incompetence
Cervical incompetence
 
Cesarean Scar Ectopic Pregnancy Current Management Strategies
Cesarean Scar Ectopic Pregnancy Current Management StrategiesCesarean Scar Ectopic Pregnancy Current Management Strategies
Cesarean Scar Ectopic Pregnancy Current Management Strategies
 
Fibroid and infertility
Fibroid and infertilityFibroid and infertility
Fibroid and infertility
 

Similar to Maternal Near Miss

Maternal mortality rate and its prevention
Maternal mortality rate and its preventionMaternal mortality rate and its prevention
Maternal mortality rate and its prevention
AnnweshaMridha1
 
Maternal Mortality
Maternal MortalityMaternal Mortality
Maternal Mortality
Arvind Kushwaha
 
MATERNAL AND FETAL OUTCOME AMONG OBSTETRIC REFERRALS: A CASE STUDY OF THE BA...
MATERNAL AND FETAL OUTCOME  AMONG OBSTETRIC REFERRALS: A CASE STUDY OF THE BA...MATERNAL AND FETAL OUTCOME  AMONG OBSTETRIC REFERRALS: A CASE STUDY OF THE BA...
MATERNAL AND FETAL OUTCOME AMONG OBSTETRIC REFERRALS: A CASE STUDY OF THE BA...
GABRIEL JEREMIAH ORUIKOR
 
MATERNAL AND FETAL OUTCOME AMONG OBSTETRIC REFERRALS: A CASE STUDY OF THE BA...
MATERNAL AND FETAL OUTCOME  AMONG OBSTETRIC REFERRALS: A CASE STUDY OF THE BA...MATERNAL AND FETAL OUTCOME  AMONG OBSTETRIC REFERRALS: A CASE STUDY OF THE BA...
MATERNAL AND FETAL OUTCOME AMONG OBSTETRIC REFERRALS: A CASE STUDY OF THE BA...
GABRIEL JEREMIAH ORUIKOR
 
Safe prevention of the primary cesarean delivery
Safe prevention of the primary cesarean deliverySafe prevention of the primary cesarean delivery
Safe prevention of the primary cesarean delivery
Aboubakr Elnashar
 
Saving Mothers and Babies: Maternal mortality
Saving Mothers and Babies: Maternal mortalitySaving Mothers and Babies: Maternal mortality
Saving Mothers and Babies: Maternal mortality
Saide OER Africa
 
G424472.pdf
G424472.pdfG424472.pdf
Fetal monitoring rcog
Fetal monitoring rcogFetal monitoring rcog
Fetal monitoring rcog
Norman Triantoro
 
Epidemiology and carcinogenesis of premalignant lesions of cervix
Epidemiology and carcinogenesis  of premalignant lesions of cervixEpidemiology and carcinogenesis  of premalignant lesions of cervix
Epidemiology and carcinogenesis of premalignant lesions of cervix
Maninder Ahuja
 
Maternal mortality in egypt
Maternal mortality in egyptMaternal mortality in egypt
Maternal mortality in egypt
Aboubakr Elnashar
 
HOW TO REDUCE CS RATES?
HOW TO REDUCE CS RATES?HOW TO REDUCE CS RATES?
HOW TO REDUCE CS RATES?
Aboubakr Elnashar
 
Clinical Features & Diagnosis of Maternal Sepsis
Clinical Features & Diagnosis of Maternal SepsisClinical Features & Diagnosis of Maternal Sepsis
Clinical Features & Diagnosis of Maternal Sepsis
Dr.Laxmi Agrawal Shrikhande
 
Vital statistics related to maternal health in india
Vital statistics related to maternal health in indiaVital statistics related to maternal health in india
Vital statistics related to maternal health in india
Priyanka Gohil
 
ENDALE PROM ARTICLE.pdf
ENDALE PROM ARTICLE.pdfENDALE PROM ARTICLE.pdf
ENDALE PROM ARTICLE.pdf
muzcseb
 
Aboriginal Patterns of Cancer Care Project Breast Cancer paper BMCCancer 1471...
Aboriginal Patterns of Cancer Care Project Breast Cancer paper BMCCancer 1471...Aboriginal Patterns of Cancer Care Project Breast Cancer paper BMCCancer 1471...
Aboriginal Patterns of Cancer Care Project Breast Cancer paper BMCCancer 1471...
Cancer Council NSW
 
vital statistics related to maternal health in indIA.pptx
vital statistics related to maternal health in indIA.pptxvital statistics related to maternal health in indIA.pptx
vital statistics related to maternal health in indIA.pptx
Anju Kumawat
 

Similar to Maternal Near Miss (20)

Maternal mortality rate and its prevention
Maternal mortality rate and its preventionMaternal mortality rate and its prevention
Maternal mortality rate and its prevention
 
Maternal Mortality
Maternal MortalityMaternal Mortality
Maternal Mortality
 
MATERNAL AND FETAL OUTCOME AMONG OBSTETRIC REFERRALS: A CASE STUDY OF THE BA...
MATERNAL AND FETAL OUTCOME  AMONG OBSTETRIC REFERRALS: A CASE STUDY OF THE BA...MATERNAL AND FETAL OUTCOME  AMONG OBSTETRIC REFERRALS: A CASE STUDY OF THE BA...
MATERNAL AND FETAL OUTCOME AMONG OBSTETRIC REFERRALS: A CASE STUDY OF THE BA...
 
MATERNAL AND FETAL OUTCOME AMONG OBSTETRIC REFERRALS: A CASE STUDY OF THE BA...
MATERNAL AND FETAL OUTCOME  AMONG OBSTETRIC REFERRALS: A CASE STUDY OF THE BA...MATERNAL AND FETAL OUTCOME  AMONG OBSTETRIC REFERRALS: A CASE STUDY OF THE BA...
MATERNAL AND FETAL OUTCOME AMONG OBSTETRIC REFERRALS: A CASE STUDY OF THE BA...
 
Maternal near miss
Maternal near missMaternal near miss
Maternal near miss
 
KLandry_Thesis_2015
KLandry_Thesis_2015KLandry_Thesis_2015
KLandry_Thesis_2015
 
Safe prevention of the primary cesarean delivery
Safe prevention of the primary cesarean deliverySafe prevention of the primary cesarean delivery
Safe prevention of the primary cesarean delivery
 
IJMPR43122-515-529.docx
IJMPR43122-515-529.docxIJMPR43122-515-529.docx
IJMPR43122-515-529.docx
 
Saving Mothers and Babies: Maternal mortality
Saving Mothers and Babies: Maternal mortalitySaving Mothers and Babies: Maternal mortality
Saving Mothers and Babies: Maternal mortality
 
G424472.pdf
G424472.pdfG424472.pdf
G424472.pdf
 
06 Obstetric Care
06 Obstetric Care06 Obstetric Care
06 Obstetric Care
 
Fetal monitoring rcog
Fetal monitoring rcogFetal monitoring rcog
Fetal monitoring rcog
 
Epidemiology and carcinogenesis of premalignant lesions of cervix
Epidemiology and carcinogenesis  of premalignant lesions of cervixEpidemiology and carcinogenesis  of premalignant lesions of cervix
Epidemiology and carcinogenesis of premalignant lesions of cervix
 
Maternal mortality in egypt
Maternal mortality in egyptMaternal mortality in egypt
Maternal mortality in egypt
 
HOW TO REDUCE CS RATES?
HOW TO REDUCE CS RATES?HOW TO REDUCE CS RATES?
HOW TO REDUCE CS RATES?
 
Clinical Features & Diagnosis of Maternal Sepsis
Clinical Features & Diagnosis of Maternal SepsisClinical Features & Diagnosis of Maternal Sepsis
Clinical Features & Diagnosis of Maternal Sepsis
 
Vital statistics related to maternal health in india
Vital statistics related to maternal health in indiaVital statistics related to maternal health in india
Vital statistics related to maternal health in india
 
ENDALE PROM ARTICLE.pdf
ENDALE PROM ARTICLE.pdfENDALE PROM ARTICLE.pdf
ENDALE PROM ARTICLE.pdf
 
Aboriginal Patterns of Cancer Care Project Breast Cancer paper BMCCancer 1471...
Aboriginal Patterns of Cancer Care Project Breast Cancer paper BMCCancer 1471...Aboriginal Patterns of Cancer Care Project Breast Cancer paper BMCCancer 1471...
Aboriginal Patterns of Cancer Care Project Breast Cancer paper BMCCancer 1471...
 
vital statistics related to maternal health in indIA.pptx
vital statistics related to maternal health in indIA.pptxvital statistics related to maternal health in indIA.pptx
vital statistics related to maternal health in indIA.pptx
 

More from Aboubakr Elnashar

WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGISTWHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
Aboubakr Elnashar
 
hepatitis B.pdf
hepatitis B.pdfhepatitis B.pdf
hepatitis B.pdf
Aboubakr Elnashar
 
hepatitis c2022.pdf
hepatitis c2022.pdfhepatitis c2022.pdf
hepatitis c2022.pdf
Aboubakr Elnashar
 
Adenomyosis associated infertility
Adenomyosis associated  infertilityAdenomyosis associated  infertility
Adenomyosis associated infertility
Aboubakr Elnashar
 
Endometriosis associated infertility: ESHRE2022
Endometriosis associated infertility: ESHRE2022Endometriosis associated infertility: ESHRE2022
Endometriosis associated infertility: ESHRE2022
Aboubakr Elnashar
 
Adenxal mass guidelines2020
Adenxal mass guidelines2020Adenxal mass guidelines2020
Adenxal mass guidelines2020
Aboubakr Elnashar
 
Aesthetic gynecology controversy
Aesthetic gynecology controversyAesthetic gynecology controversy
Aesthetic gynecology controversy
Aboubakr Elnashar
 
Hormonal assay in clinical gyn
Hormonal assay in clinical gynHormonal assay in clinical gyn
Hormonal assay in clinical gyn
Aboubakr Elnashar
 
FIRST TRIMESTER ANC OF IVF
FIRST TRIMESTER ANC OF IVFFIRST TRIMESTER ANC OF IVF
FIRST TRIMESTER ANC OF IVF
Aboubakr Elnashar
 
Unnecessary investigations in reproductive medicine
Unnecessary investigations in reproductive medicineUnnecessary investigations in reproductive medicine
Unnecessary investigations in reproductive medicine
Aboubakr Elnashar
 
Infertility prevention
Infertility prevention Infertility prevention
Infertility prevention
Aboubakr Elnashar
 
Individualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulationIndividualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulation
Aboubakr Elnashar
 
Female infertility
Female infertility Female infertility
Female infertility
Aboubakr Elnashar
 
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
Aboubakr Elnashar
 
cesarean birth: procedural aspects: NICE2021
cesarean birth: procedural aspects: NICE2021  cesarean birth: procedural aspects: NICE2021
cesarean birth: procedural aspects: NICE2021
Aboubakr Elnashar
 
CAESAREAN SCAR DEFECT
CAESAREAN SCAR DEFECT  CAESAREAN SCAR DEFECT
CAESAREAN SCAR DEFECT
Aboubakr Elnashar
 
Management of pregnancy of unknown location
Management of pregnancy of unknown locationManagement of pregnancy of unknown location
Management of pregnancy of unknown location
Aboubakr Elnashar
 
Aerobic Vaginitis
Aerobic Vaginitis Aerobic Vaginitis
Aerobic Vaginitis
Aboubakr Elnashar
 
COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021
Aboubakr Elnashar
 
Imaging in pregnancy 2 in1
Imaging in pregnancy 2 in1Imaging in pregnancy 2 in1
Imaging in pregnancy 2 in1
Aboubakr Elnashar
 

More from Aboubakr Elnashar (20)

WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGISTWHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
WHAT IS NEW IN ESHRE 2022 AND FIGO 2022 FOR GENERAL GYNAECOLOGIST
 
hepatitis B.pdf
hepatitis B.pdfhepatitis B.pdf
hepatitis B.pdf
 
hepatitis c2022.pdf
hepatitis c2022.pdfhepatitis c2022.pdf
hepatitis c2022.pdf
 
Adenomyosis associated infertility
Adenomyosis associated  infertilityAdenomyosis associated  infertility
Adenomyosis associated infertility
 
Endometriosis associated infertility: ESHRE2022
Endometriosis associated infertility: ESHRE2022Endometriosis associated infertility: ESHRE2022
Endometriosis associated infertility: ESHRE2022
 
Adenxal mass guidelines2020
Adenxal mass guidelines2020Adenxal mass guidelines2020
Adenxal mass guidelines2020
 
Aesthetic gynecology controversy
Aesthetic gynecology controversyAesthetic gynecology controversy
Aesthetic gynecology controversy
 
Hormonal assay in clinical gyn
Hormonal assay in clinical gynHormonal assay in clinical gyn
Hormonal assay in clinical gyn
 
FIRST TRIMESTER ANC OF IVF
FIRST TRIMESTER ANC OF IVFFIRST TRIMESTER ANC OF IVF
FIRST TRIMESTER ANC OF IVF
 
Unnecessary investigations in reproductive medicine
Unnecessary investigations in reproductive medicineUnnecessary investigations in reproductive medicine
Unnecessary investigations in reproductive medicine
 
Infertility prevention
Infertility prevention Infertility prevention
Infertility prevention
 
Individualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulationIndividualisation of controlled ovarian stimulation
Individualisation of controlled ovarian stimulation
 
Female infertility
Female infertility Female infertility
Female infertility
 
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
THE MANAGEMENT OF SEVERE PET/ECLAMPSIA
 
cesarean birth: procedural aspects: NICE2021
cesarean birth: procedural aspects: NICE2021  cesarean birth: procedural aspects: NICE2021
cesarean birth: procedural aspects: NICE2021
 
CAESAREAN SCAR DEFECT
CAESAREAN SCAR DEFECT  CAESAREAN SCAR DEFECT
CAESAREAN SCAR DEFECT
 
Management of pregnancy of unknown location
Management of pregnancy of unknown locationManagement of pregnancy of unknown location
Management of pregnancy of unknown location
 
Aerobic Vaginitis
Aerobic Vaginitis Aerobic Vaginitis
Aerobic Vaginitis
 
COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021COVID 19 infection and pregnancy RCOG2021
COVID 19 infection and pregnancy RCOG2021
 
Imaging in pregnancy 2 in1
Imaging in pregnancy 2 in1Imaging in pregnancy 2 in1
Imaging in pregnancy 2 in1
 

Recently uploaded

Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 

Recently uploaded (20)

Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 

Maternal Near Miss

  • 1. Maternal Near Miss Prof. Aboubakr Elnashar Benha University Hospital, Egypt elnashar53@hotmail.com ABOUBAKR ELNASHAR
  • 2. CONTENTS I. MATERNAL MORTALITY 1. Definitions 2. Why is not sufficient? II. MATERNAL NEAR MISS 1. Concept 2. Definition 3. Criteria 4. Indicators 5. Review 6. Advantages 7. Reduction of MM 8. Studies  CONCLUSION ABOUBAKR ELNASHAR
  • 3. I. MATERNAL MORTALITY 1. DEFINITIONS Maternal Death: MD The death of a woman while pregnant, or within 42 days of termination of pregnancy, irrespective of the duration and the site of the pregnancy, from any cause related to or aggravated by the pregnancy or its management (from direct or indirect obstetric death) but not from accidental or incidental causes. ABOUBAKR ELNASHAR
  • 4. Maternal Mortality Rate Vs Ratio Many sources use the maternal mortality ratio and the maternal mortality rate interchangeably to mean the number of maternal deaths per 100,000 live births. WHO, however, distinguishes the two: ABOUBAKR ELNASHAR
  • 5. Maternal mortality ratio: The number of maternal deaths per 100,000 live births a measure of the risk of death once a woman has become pregnant. In Egypt: 2016 Number of maternal deaths: 1194 Live births: 2 600 173 MM Ratio: 45.9 ABOUBAKR ELNASHAR
  • 6. Maternal mortality rate: The number of maternal deaths (direct and indirect) in a given period per 100,000 women of reproductive age during the same time period. ABOUBAKR ELNASHAR
  • 7. 2. WHY MM IS NOT SUFFICIENT?  Maternal mortality (MM)  Now not considered sufficient for evaluation of obstetric health in isolation. 1. Maternal mortality is  “just the tip of iceberg” with a vast base to the iceberg-maternal morbidity-which  remains un-described,  relatively unevaluated. ABOUBAKR ELNASHAR
  • 9. 2. MMR has declined globally, more so in developed countries. 3. Absolute number of maternal deaths is low  it does not allow reliable quantitative analysis of maternal health.  In Egypt MMR has fallen from 1992: 174 2016: 46 ABOUBAKR ELNASHAR
  • 10. 3. Trends Significant decline in the past 20 years. From 2007 to 2013, there is no significant decrease in MMR 46 2016 ABOUBAKR ELNASHAR
  • 11. II. MATERNAL NEAR MISS 1.CONCEPT  Maternal near miss =  Severe Acute Maternal Morbidity (SAMM)  Women who experienced and survived a severe life threatening condition during pregnancy, child birth / postpartum  cases share many characteristics with maternal deaths ABOUBAKR ELNASHAR
  • 12.  Maternal near miss =  emerged as  an adjunct and proxy measure to identify gaps in maternal health services  complementary to maternal mortality  inform about obstacles that have to be overcome after the onset of an acute complication.  Corrective actions for identified problems  can then be taken to reduce related mortality and long-term morbidity. ABOUBAKR ELNASHAR
  • 13. 2. DEFINITION  “a woman who nearly died but survived a complication that occurred during pregnancy, childbirth or within 42 days of termination of pregnancy” (WHO,2004)  In practical terms  women are considered near miss cases when they survive life-threatening conditions (i.e. organ dysfunction).  Woman who survives life threatening conditions during pregnancy, abortion, and childbirth or within 42 days of pregnancy termination, irrespective of receiving emergency medical/surgical interventions. (Souza et al, 2007) ABOUBAKR ELNASHAR
  • 14. 3. CRITERIA FOR IDENTIFICATION WHO recommended 3 approaches 1. Disease specific criteria severe preeclampsia/eclampsia severe hemorrhage severe sepsis uterine rupture. 2. Management/Intervention based admission to ICU obstetric hysterectomy massive blood transfusion intubation/ventilation. ABOUBAKR ELNASHAR
  • 15. 3. Organ dysfunction based criteria –  based on  apparent clinical diseases,  clinical markers  management needs.  The aim  correction of that organ dysfunction  arrest MNM progression to MD. ABOUBAKR ELNASHAR
  • 18. 4. INDICATORS  Useful for  auditing quality of maternal health care  assessing deficiencies and gaps between actual use and optimal use of high priority interventions in prevention and management of severe pregnancy complications. ABOUBAKR ELNASHAR
  • 19. 1. Severe maternal outcome ratio (SMOR)  number of women with life-threatening conditions (MNM + MD) per 1000 live births (LB).  This gives an estimate of  the amount of care  resources that would be needed in an area or facility  [SMOR= (MNM +MD)/LB]. ABOUBAKR ELNASHAR
  • 20. 2. MNM ratio (MNMR)  number of maternal near-miss cases per 1000 live births  (MNMR = MNM/LB).  It gives an estimation of  the amount of care  resources that would be needed in an area or facility. ABOUBAKR ELNASHAR
  • 21. 3. Maternal near-miss mortality ratio  (MNM: 1 MD)  refers to the ratio between maternal near-miss cases and maternal deaths.  Higher ratios indicate better care. ABOUBAKR ELNASHAR
  • 22. 4. Mortality index  number of maternal deaths divided by number of women with life-threatening conditions  expressed as a percentage [MI= MD/ (MNM + MD)].  The higher the index the more women with life- threatening conditions die (low quality of care)  The lower the index the fewer women with life- threatening conditions die (better quality of care). ABOUBAKR ELNASHAR
  • 23. 5. WHAT IS MNM REVIEW?  Process of MNM Review (MNM-R) involves the following steps: 1. Identification of MNM cases 2. Notification to MO/HOD 3. Data transmission (institute district state) 4. Review (institutional and district level) 5. Analysis and feedback for necessary action ABOUBAKR ELNASHAR
  • 24. 6. ADVANTAGES 1. Near miss cases are more common than maternal deaths:  adequate information and analysis.  statistically reliable quantitative analysis  comprehensive profile of functioning of health care system. ABOUBAKR ELNASHAR
  • 25. 2. MNM shares MM.  same pathway and pathological processes as  Normal pregnancy  Morbidity  severe morbidity  near miss  Death  The major reasons and causes: valuable information regarding severe morbidity, which, if untreated may lead to MM. ABOUBAKR ELNASHAR
  • 26. 3. MNM-R seems to be less threatening to service providers.  In Cases of MDR, health professionals and other stakeholders involved in service delivery are fearful that the blame would fall on their shoulders.  MDR process is considered as a potential threat to expose them to public enquiry and outrage.  Investigating the instances of MNM-R may be less threatening to providers because the woman survived.  In MNM R, fear of blame and punishment is less.  are willing and eager to share their „success‟ stories.  more valuable information can be obtained and utilized for improvement of obstetric health and reduction of MMR. ABOUBAKR ELNASHAR
  • 27. 4. It enables us to learn from MNM survivors as women themselves are available for interview about the care they received. They can share their experiences in ICU, psychological devastation and trauma of being separated from newborn and urge for breastfeeding, besides the psychological perspective of other women who have faced severe maternal illness. ABOUBAKR ELNASHAR
  • 28. 5. MNM-R provides valuable information about  social and family problems  lack of awareness of health care facilities.  Level of delays can also be identified where they occur. ABOUBAKR ELNASHAR
  • 29. 7. SIGNIFICANCE IN REDUCING MATERNAL MORTALITY  MNM-R  relatively simpler to analyze  easier to resolve  complementary to MDR in appraisal of maternal health. ABOUBAKR ELNASHAR
  • 30.  When used in conjunction with MDR 1. aids in recognizing patterns and trends of maternal morbidity and mortality 2. helps in identifying contributory factors of maternal deaths so that actions can be taken at various levels. 3. assists in evaluation of quality of health care at a facility and to monitor it. 4. facilitates detection of lacunae in existing system. ABOUBAKR ELNASHAR
  • 31. 5. helps in setting up a database to capture all locations and facility details to identify where an MNM case comes from; this assists in focusing interventions in a particular location. 6. beneficial in assessing and analyzing requirement of health care facilities in terms of infrastructure, human resources and interventional facilities, besides comparing the existing health care and optimal health care of a facility. ABOUBAKR ELNASHAR
  • 32. 7. identification of delays at various levels can be done, which lead to maternal morbidity and mortality 8. identify modifiable socio-demographic factors responsible for maternal morbidity and mortality. 9. It assists in international comparisons in imparting optimal health care. ABOUBAKR ELNASHAR
  • 33. 8. STUDIES Arab countries  Maternal mortality index  Al Galaa hospital Egypt: 8.6 %  Dar Al Tawleed hospital in Syria: 14.3 %  countries with a moderate maternal mortality ratio :5.6 % (Bashour et al, 2015) ABOUBAKR ELNASHAR
  • 34.  MNM cases:  haemorrhage-related complications were the most frequent conditions MNM dysfunction: coagulation dysfunctions cardiovascular dysfunctions. (Bashour et al, 2015) ABOUBAKR ELNASHAR
  • 35. Kasr eleny Hospital  The most common diagnosis encountered was  Eclampsia: 58.7%  Preeclampsia: 17.4%,  APH and PPH: 8.7%  Septic shock: 4.3%  APP plus PPH in 2.2% (Almonerary et al, 2012) ABOUBAKR ELNASHAR
  • 36. Number Percent Organ dysfunction* Cardiovascular dysfunction 76 59.4% Respiratory dysfunction 8 6.3% Renal dysfunction 4 3.1% Coagulation/haematologic dysfunction 96 75.0% Hepatic dysfunction 16 12.5% Neurologic dysfunction 8 6.3% Uterine hysterectomy 28 21.9% Elgalaa Hospital Organ dysfunction in Near-Miss Women (N=128) (Elshishini et al, 2018) ABOUBAKR ELNASHAR
  • 37.  Near miss clinical audit:  improve  performance and quality of care  maternal health outcome indicators.  The Severe Maternal outcome  can be used to monitor and assess the performance and health care level. ABOUBAKR ELNASHAR
  • 38. Mansura university Hospital Number and % of distribution of MNM and dead women who experienced organ dysfunctions (Mesbach et al, 2018) ABOUBAKR ELNASHAR
  • 39.  The main life threatening sever pre-eclampsia sever post partum hemorrhage.  Cesarean Section was the main delivery mood for the near misses (93%). ABOUBAKR ELNASHAR
  • 40. Elshatby university Hospital  Severe pre-eclampsia: 40.2%  post-partum hemorrhage: 23.8%  Mortality index: 8.5%. . (Sultan et al, 2017) ABOUBAKR ELNASHAR
  • 41. CONCLUSION  Investigating MNM cases aids in taking measures for further improvement of service delivery and programs.  MNM is a vital tool that can go a long way in reducing maternal mortality.  MNM-R  an eminent adjunctive strategy to help identify gaps in health service provision. ABOUBAKR ELNASHAR
  • 42.  MNM-R and MDR are complementary to each other.  When used together, they help in recognizing the contributory factors of maternal deaths so that appropriate actions can be adopted at community and health systems level. ABOUBAKR ELNASHAR